Key facts
- This page summarizes Stephen H. Willard's Form 4 filing for NRX Pharmaceuticals, Inc. (NRXP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Dec 2022, 06:14.
Stephen H. Willard - 16 Dec 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- NRXP
- Reported as of
- 16 Dec 2022
- Net transaction value
- +$58,500
- SEC form
- 4
- Accepted by SEC
- 19 Dec 2022, 06:14:23 UTC
- Prior SEC filing
- 22 Jul 2022
- Next SEC filing
- 13 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Willard
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen H. Willard filed Form 4 for NRX Pharmaceuticals, Inc. (NRXP) on 19 Dec 2022.
Change
- Previous filing in this sequence was filed on 22 Jul 2022.
- Current net transaction value: +$58,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NRXP
transaction
Common Stock, par value $0.001 per share
Purchase
- Transaction value
- $58,500
- Shares
- +50,000
- Change %
- Price
- $1.17
- Shares after
- 50,000
- Date
- 16 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.20. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.